Tabs
Publications related to this Person
Journal articles
Georgiou E; Sidiropoulou K; Richter J; Papaneophytou C; Sargiannidou I; Kagiava A; von Jonquieres G; Christodoulou C; Klugmann M; Kleopa KA, 2017, 'Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model', Brain : a journal of neurology, vol. 140, pp. 599 - 616, http://dx.doi.org/10.1093/brain/aww351
Szumlinski KK; Lominac KD; Campbell RR; Cohen M; Fultz EK; Brown CN; Miller BW; Quadir SG; Martin D; Thompson AB, 2017, 'Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly', Biological Psychiatry, vol. 81, pp. 959 - 970, http://dx.doi.org/10.1016/j.biopsych.2016.10.005
Fröhlich D; Suchowerska AK; Spencer ZHT; von Jonquieres G; Klugmann CB; Bongers A; Delerue F; Stefen H; Ittner LM; Fath T, 2017, 'In vivo characterization of the aspartyl-tRNA synthetase DARS: Homing in on the leukodystrophy HBSL', Neurobiology of Disease, vol. 97, pp. 24 - 35, http://dx.doi.org/10.1016/j.nbd.2016.10.008
O'Brien R; Tran SL; Maritz MF; Liu B; Kong CF; Purgato S; Yang C; Murray J; Russell AJ; Flemming CL, 2016, 'MYC-driven neuroblastomas are addicted to a telomerase-independent function of dyskerin', Cancer Research, vol. 76, pp. 3604 - 3617, http://dx.doi.org/10.1158/0008-5472.CAN-15-0879
von Jonquieres G; Fröhlich D; Klugmann CB; Wen X; Harasta AE; Ramkumar R; Spencer ZHT; Housley GD; Klugmann M, 2016, 'Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes', Frontiers in Molecular Neuroscience, vol. 9, http://dx.doi.org/10.3389/fnmol.2016.00013
Harasta AE; Power JM; von Jonquieres G; Karl T; Drucker DJ; Housley GD; Schneider M; Klugmann M, 2015, 'Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior', Neuropsychopharmacology, http://dx.doi.org/10.1038/npp.2015.47
Von Jonquieres G; Froud KE; Klugmann CB; Wong ACY; Housley GD; Klugmann M, 2014, 'Loss of central auditory processing in a mouse model of canavan disease', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0097374
Cozzoli DK; Courson J; Wroten MG; Greentree DI; Lum EN; Campbell RR; Thompson AB; Maliniak D; Worley PF; Jonquieres G, 2014, 'Binge alcohol drinking by mice requires intact group1 metabotropic glutamate receptor signaling within the Central nucleus of the Amygdale', Neuropsychopharmacology, vol. 39, pp. 435 - 444, http://dx.doi.org/10.1038/npp.2013.214
Gould AT; Sacramento AD; Wroten MG; Miller BW; von Jonquieres G; Klugmann M; Ben-Shahar O; Szumlinski KK, 2013, 'Cocaine-elicited imbalances in ventromedial prefrontal cortex homer1 versus homer2 expression: Implications for relapse', Addiction Biology, http://dx.doi.org/10.1111/adb.12088
Obara I; Goulding SP; Gould AT; Lominac KD; Hu JH; Zhang PW; von Jonquieres G; Dehoff M; Xiao B; Seeburg PH, 2013, 'Homers at the interface between reward and pain', Frontiers in Psychiatry, vol. 4
von Jonquieres G; Mersmann N; Klugmann CB; Harasta AE; Lutz B; Teahan O; da Housley G; Fröhlich D; Krämer-Albers EM; Klugmann M, 2013, 'Glial Promoter Selectivity following AAV-Delivery to the Immature Brain', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0065646
Ary AW; Lominac KD; Wroten MG; Williams AR; Campbell RR; Ben-Shahar O; von Jonquieres G; Klugmann M; Szumlinski KK, 2013, 'Imbalances in prefrontal cortex CC-Homer1 versus CC-Homer2 expression promote cocaine preference', Journal of Neuroscience, vol. 33, pp. 8101 - 8113, http://dx.doi.org/10.1523/JNEUROSCI.1727-12.2013
Thoms JAI; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH, 2011, 'ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer', Blood, vol. 117, pp. 7079 - 7089, http://dx.doi.org/10.1182/blood-2010-12-317990
Callister RJ, 2010, 'Early history of glycine receptor biology in mammalian spinal cord circuits', Frontiers in Molecular Neuroscience, vol. 3, http://dx.doi.org/10.3389/fnmol.2010.00013
Marshall GM; Gherardi S; Xu N; Neiron Z; Trahair T; Scarlett CJ; Chang DK; Liu PY; Jankowski K; Iraci N, 2010, 'Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects', Oncogene, vol. 29, pp. 5957 - 5968, http://dx.doi.org/10.1038/onc.2010.332
Von Jonquieres G, 2010, 'Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects', Oncogene, vol. 29, pp. 5957 - 5968, http://dx.doi.org/10.1038/onc.2010.332
Eckstein N; Servan K; Hildebrandt B; Pölitz A; Von Jonquières G; Wolf-Kümmeth S; Napierski I; Hamacher A; Kassack MU; Budczies J, 2009, 'Hyperactivation of the insulin-like growth factor receptor I signaling pathway Is an essential event for cisplatin resistance of ovarian cancer cells', Cancer Research, vol. 69, pp. 2996 - 3003, http://dx.doi.org/10.1158/0008-5472.CAN-08-3153
Eckstein N; Servan K; Girard L; Cai D; Von Jonquieres G; Jaehde U; Kassack MU; Gazdar AF; Minna JD; Royer HD, 2008, 'Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells', Journal of Biological Chemistry, vol. 283, pp. 739 - 750, http://dx.doi.org/10.1074/jbc.M706287200
Gosepath EM; Eckstein N; Hamacher A; Servan K; Von Jonquieres G; Lage H; Györffy B; Royer HD; Kassack MU, 2008, 'Acquired cisplatin resistance in the head-neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1', International Journal of Cancer, vol. 123, pp. 2013 - 2019, http://dx.doi.org/10.1002/ijc.23721
School of Medical Sciences - Wallace Wurth Building, UNSW Sydney NSW 2052 Australia | Contacts
© Copyright 2012 UNSW Medicine | CRICOS Provider Code: 00098G | ABN 57 195 873 179 | Authorised by Head of School of Medical Sciences